CHICAGO & MINNEAPOLIS--(BUSINESS WIRE)--May. 21, 2012--
Avery
Dennison Medical Solutions today announced a partnership with Preventice,
Inc., to produce patch-based wearable sensors for clinical monitoring of
a patient’s unique physiological characteristics.
Preventice is a break-through developer of mobile health applications
and patient monitoring systems that deliver continuous care, wherever an
individual might be. Mobile health applications, like those developed by
Preventice, improve the doctor-patient relationship by establishing a
constant connection and exchange of information between care providers
and their patients. This connection encourages patients to stay engaged
in actively managing their health while away from their health care
providers, and feeds data to clinicians about a patient’s health status
without impacting their daily lifestyle.
“Preventice has a unique understanding of clinical care delivery, which
when combined with their expertise in mobile device platforms, remote
monitoring protocols, algorithms, data management and EMR
integration, gives us an advantage in the marketplace,” said Howard
Kelly, vice president and general manager, Avery Dennison Medical
Solutions. “Together, we will leverage these strengths, along with
Metria Wearable Sensor Technology, to offer clinical remote monitoring
applications that address the unmet needs of health care providers,
while helping improve patients’ quality of life and reducing costs.”
Through this partnership, Avery Dennison Medical Solutions will develop
a new version of the Metria™
patch-based wearable sensor and user interface for the Preventice
Care Platform, which creates a real-time, continuous connection
between patients and health care providers through mobile, cloud-based
and sensor technology. The Metria* solution, which
incorporates sensor technology from Proteus
Biomedical, will be sold as part of the Preventice Care Platform for
remote monitoring applications to hospitals and health care systems in
the United States.
“The potential to improve clinical care through the use of on-body
sensors and remote monitoring is endless,” said Jon Otterstatter,
co-founder, president and CEO of Preventice. “We’re confident that the
addition of Avery Dennison Medical Solutions to our ecosystem of
partners who are focused on health care innovation creates a new level
of sophistication in monitoring technology. It also supports
Preventice’s laser-focus on providing physicians with new monitoring
solutions to significantly improve the patient experience and clinical
outcomes.”
Avery Dennison Medical Solutions, a business unit of Avery
Dennison Corporation (NYSE: AVY), leverages its expertise in
advanced skin adhesives and material sciences to develop innovative
technologies for medical applications. The company has licensed
proprietary algorithms from Preventice for additional clinical
applications of the Metria patch-based wearable sensor, which Avery
Dennison will continue to manufacture for both partner companies and
their respective customers.
www.medical.averydennison.com/Metria
*Metria Wearable Sensor Technology products have not been evaluated by
Regulatory Agencies.
About Avery Dennison
Avery Dennison (NYSE:AVY) helps make brands more inspiring and the world
more intelligent. The company is a global leader in pressure-sensitive
technology and materials and retail branding and information solutions.
A FORTUNE 500 company with sales of $6 billion from continuing
operations in 2011, Avery Dennison is based in Pasadena, California and
has employees in over 60 countries. For more information, visit www.averydennison.com.
About Preventice
Preventice is a privately owned company and leading developer of mobile
health applications and remote monitoring systems that connect mobile,
home-based, and on-premise technologies to deliver continuous patient
care across the health continuum—wherever an individual patient might
be. Applications from Preventice create a constant connection and
exchange of data between health care providers, life science companies
and their patients. Current applications from Preventice address
high-cost conditions and health management opportunities, including
prescription medication management, cardiac care, sleep apnea, diabetes
management, and migraine headaches. Preventice is headquartered in
Minneapolis, with offices in Rochester, Minn., and Fargo, N.D. For more
information, visit www.preventice.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50282119&lang=en
Source: Avery Dennison
Avery Dennison Medical Solutions
Bob
Giuliano, +1-610-328-1051
Bob.Giuliano@prplace.biz
or
Kate
Franco, +1-312-206-1037
Kate.Franco@averydennison.com
or
Preventice
Colleen
Kulhanek, +1-651-307-9486
CKulhanek@preventice.com
